HSTC
HST Global, Inc. [HSTC] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
HSTC Stock Summary
Top 10 Correlated ETFs
HSTC
Top 10 Correlated Stocks
HSTC
In the News
HSTC Financial details
Company Rating
-
Market Cap
5.88M
Income
-148.63K
Revenue
0
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
-
Optionable
No
Shortable
Yes
Earnings
31 Mar 2023
P/E
-12.66
Forward P/E
-
PEG
-58.24
P/S
-
P/B
-3.36
P/C
-
P/FCF
-93.25
Quick Ratio
-
Current Ratio
-
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-0.03
EPS next Y
-
EPS next Q
-
EPS this Y
1.09%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
2.94%
-
-
-
-
SMA20
-10.84%
SMA50
-11.9%
SMA100
-28.85%
Inst Own
-
Inst Trans
-
ROA
-7372%
ROE
29%
ROC
0.25%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.1-1.15
52W High
-
52W Low
-
RSI
39.29
Rel Volume
4.8
Avg Volume
249
Volume
1.2K
Perf Week
2.74%
Perf Month
-9.64%
Perf Quarter
15.38%
Perf Half Y
-28.57%
-
-
-
-
Beta
-0.992
-
-
Volatility
0.01%, 0.05%
Prev Close
0%
Price
0.75
Change
0%
Company Profile
- Volume Average 249
- Market Capitalization 5.88M
- CEO Mr. Ronald R. Howell
- Headquarters Hampton,VA,US
- IPO Date 2002-06-24
-
Website
https://www.hstglobal.com 
HST Global, Inc., an integrated health and wellness biotechnology company, develops and/or acquires a network of wellness centers for the homeopathic and alternative treatment of late stage cancer worldwide. It also focuses on the homeopathic and alternative product candidates that are undergoing or have already completed clinical testing for the treatment of late stage cancers and other life-threatening diseases. HST Global, Inc. is headquartered in Hampton, Virginia.
